, China
352 views
/Steve Long from Unsplash

China's insurance premiums increase by 5.1% YoY

Year-to-date, the industry’s assets climbed 10.4%.

Total assets of Chinese insurance companies stood at RMB32.9t ($4.60t) in the first quarter (Q1 2024), a 10.4% increase from the beginning of the year, data from the National Financial Regulatory Administration (NFRA) showed.

Property and casualty insurance assets reached RMB2.9t ($0.41t), up 4.4%; personal insurance assets were RMB28.6t ($4.00t), also up 4.4%; reinsurance assets totalled RMB775.1b ($108.52b), up 3.8%; and insurance asset management assets were RMB120.9b ($16.93b), up 14.9%.

During the same period, insurance companies recorded RMB2.2t ($0.31t) in primary insurance premium income, a 5.1% increase year-on-year (YoY). 

Insurance claim and benefit payments reached RMB735.2b ($102.93b), a 47.8% increase YoY, with 20.6b new insurance policies issued, up by 30.1% YoY.

As of Q1 2024, the comprehensive solvency ratio of the insurance sector was 195.6%, and the core solvency ratio was 130.3%. 

The comprehensive solvency ratios were 234.1%, 186.2%, and 264.4% for property and casualty insurance, personal insurance, and reinsurance companies, respectively, while the core solvency ratios were 206.3%, 113.5%, and 229.1%.

($1.00 = RMB7.25)

 

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.